<DOC>
	<DOCNO>NCT00539474</DOCNO>
	<brief_summary>Rationale : Approximately 25 % breast cancer detect non palpable . Accordingly , localization technique require help surgeon find remove cancer . The current technique ( wire guide localization [ WGL ] ) difficult perform high rate tumour positive margin resect specimen , require second operation . A new approach localization resection non-palpable malignant breast lesion 'radio guide occult lesion localization ' ( ROLL ) . ROLL introduce possible replacement WGL ` European Institute Oncology ' Milan 1996 . This technique utilize intratumourally injected radiotracer , generally use lymphatic mapping SNB , localize primary tumour guide gamma probe . Five study far proven applicability method . Objective : To evaluate efficacy Radio Occult Lesion Localisation ( ROLL ) versus Wire guide Localisation ( WGL ) breast conserve surgery non-palpable breast cancer Study design : A multicenter , prospective randomize clinical trial . Patients proven non-palpable breast cancer randomize either ROLL WGL . Study population : 316 woman core biopsy proven non palpable cT1 breast carcinoma eligible breast conserve treatment sentinel node biopsy ( SNB ) . Intervention ( applicable ) : Patients WGL group undergo intra tumoural injection nuclear radiotracer stereotactic ultrasonographic guidance . After scintigraphic imaging , monitor migration radiotracer , guide wire insert stereotactic ultrasonographic guidance . The excision primary tumour guide inserted wire sentinel node procedure perform use gamma probe intratumoural injection patent blue . Patients ROLL group undergo procedure except guide wire insertion . The excision primary tumour guide gamma probe . Main study parameters/endpoints : Primary study endpoint ; ROLL v WGL : 1 . The percentage tumour-free margin ( invasive situ ) 2 . The volume maximum diameter lumpectomy Nature extent burden risk associate participation , benefit group relatedness : There pre- , per- post operative extra burden . The radiofarmacon already use standard care breast cancer patient sentinel node biopsy . The used radio-active substance damage patient . A specific burden questionnaire , aim evaluate burden cosmetic result , administer . To assess net impact term Health Related Quality Life ( HRQoL ) also EQ5D obtain T = 0 , 6 , 12 26 week initial diagnostic work-up . Should result indicate overall WGL procedure lead well clinical outcome cost-effectiveness analysis foreseen use bootstrapping assess uncertainty regard balance cost effect . All analysis limit half year time horizon . Accordingly , discount cost effect applicable .</brief_summary>
	<brief_title>`` The Efficacy 'Radioguided Occult Lesion Localization ' ( ROLL ) Versus 'Wire-guided Localization ' ( WGL ) Breast Conserving Surgery Non-palpable Breast Cancer : Randomized Clinical Trial ''</brief_title>
	<detailed_description />
	<mesh_term>Breast Neoplasms</mesh_term>
	<criteria>Women â‰¥ 18 year , nonpalpable breast carcinoma ( cT1 ) need treat lumpectomy sentinel node biopsy Pregnant patient patient breast feed Patients multi focal tumour growth Patients ductal carcinoma situ lobular carcinoma situ core biopsy Patients require breast amputation</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2011</verification_date>
	<keyword>ROLL trial</keyword>
	<keyword>Minimally invasive surgery</keyword>
	<keyword>Non palpable breast cancer</keyword>
</DOC>